Meticulous Research®, a prominent global market research firm, has released a report titled ‘Pain Management Devices Market Size, Share, Forecast, & Trends Analysis by Product (Neurostimulation [DBS, TENS, VNS], Infusion Pump, Compression), Pain Type (Surgical, Musculoskeletal, Neuropathic, Cancer), Distribution, End User - Global Forecast to 2031.’
According to the latest findings, the pain management devices market is anticipated to achieve a value of $16.40 billion by 2031, growing at a CAGR of 5.3% throughout the forecast period. Factors fueling market expansion include the rising prevalence of chronic pain among the elderly, increased surgical procedures, and growing incidences of cancer and musculoskeletal disorders. Technological advancements in pain management devices, higher healthcare expenditures, and rising incidents of sports and accident-related injuries also contribute to market growth. However, challenges such as the high costs associated with these devices and occasional product recalls impede market progress.
Furthermore, opportunities for market growth are anticipated from partnerships and collaborations among pain management device manufacturers, integration of digital health technologies into these devices, and the expanding markets in emerging economies. Challenges include limited awareness of pain management devices in developing nations and competition from alternative technologies. Emerging trends in the market include the prominence of electrical stimulation devices and wearable pain management solutions.
Key Players
Key players in the pain management devices market include Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Boston Scientific Corporation (U.S.), Johnson & Johnson Services, Inc. (U.S.), Baxter International, Inc. (U.S.), Virpax Pharmaceuticals, Inc. (U.S.), B. Braun Melsungen AG (Germany), Medtronic plc (Ireland), Rusan Pharma Ltd (India), Grünenthal GmbH (Germany), OMRON Healthcare, Inc. (U.S.), and Nevro Corp. (U.S.).
Pain Management Devices Market: Future Outlook
The pain management devices market divides its offerings into various categories: Product types include Compression Therapy Devices (like Bandages, Garments such as Stockings, Socks & Sleeves, Wraps & Tapes, and other forms), Neurostimulation Devices (including Deep Brain Stimulation [DBS] Systems, Spinal Cord Stimulation Systems, Transcutaneous Electrical Nerve Stimulation [TENS] Systems, Vagus Nerve Stimulation [VNS] Systems, and other Neurostimulation Devices), Analgesic Infusion Pumps (covering Intrathecal Infusion Pumps and External Infusion Pumps), Electrotherapy Devices, Ablation Devices, and Accessories.
The devices are categorized by Portability, distinguishing between Stationary/Benchtop options and Wearable & Implantable solutions. They cater to different Pain Types, such as Acute Pain (linked to Injuries and Surgeries) and Chronic Pain (including Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, and other forms of Chronic Pain).
These products are distributed through various channels, including Hospital Pharmacies, Retail Pharmacies, and Online/E-commerce Platforms, and serve diverse End Users like Hospitals & Clinics, Ambulatory Surgical Centers, Physiotherapy Centers, Home Care Settings, and others. The market analysis extends to evaluating competitors within the industry and examining market dynamics at regional and national levels.
Based on product, the market for pain management devices is divided into compression therapy devices, neurostimulation devices, analgesic infusion pumps, electrotherapy devices, ablation devices, and accessories. By 2024, the compression therapy devices segment is projected to hold the largest market share at 28.1% within this sector. This significant share is primarily driven by advancements in compression therapy technology and the growing need for these devices in managing chronic pain conditions.
Based on portability, the pain management devices market is categorized into stationary/benchtop devices and wearable & implantable devices. By 2024, the wearable & implantable segment is projected to dominate the market share. This significant presence is driven by technological innovations in wearable & implantable pain management devices, which offer benefits such as real-time muscle activity tracking and immediate feedback.
Based on pain type, the pain management devices market divides into acute pain and chronic pain segments. By 2024, the chronic pain segment is anticipated to hold a larger portion of the market. This significant share is due to rising incidences of musculoskeletal diseases, neuropathic conditions, and increasing prevalence of cancer.
Based on distribution channel, the pain management devices market categorizes distribution channels into hospital pharmacies, retail pharmacies, and online/e-commerce platforms. By 2024, the retail pharmacies segment is projected to dominate the market share. This substantial share is attributed to the convenience of accessing pain management solutions at retail pharmacies, increased awareness about these devices, and the ease of availability at local pharmacy outlets.
Based on end user, the pain management devices market divides its end users into hospitals & clinics, ambulatory surgical centers, physiotherapy centers, home care settings, and other categories. By 2024, the hospitals & clinics segment is anticipated to hold the largest portion of the market. This significant share is due to an increasing number of patients seeking pain management and surgical procedures at hospitals & clinics, alongside high adoption rates of pain management devices within these healthcare facilities.
Geographic Review
This study thoroughly examines key regions and offers a comprehensive analysis of the pain management devices market across North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and other European countries), Asia-Pacific (China, Japan, India, South Korea, Australia, and other Asian countries), Latin America (Brazil, Mexico, and other Latin American countries), and the Middle East & Africa.
By 2024, North America is projected to hold the largest market share of 30.7% in the pain management devices sector, with Europe and Asia-Pacific following closely behind. North America's dominant position is influenced by the presence of leading manufacturers of pain management devices, advanced healthcare infrastructure, rising healthcare expenditures, increasing incidences of cancer and musculoskeletal disorders, and a growing number of surgical procedures conducted in the region.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5921
Key Questions Answered in the Report:
• Which market segments show high growth potential in terms of product, portability, pain type, distribution channel, end user, and region/country?
• What was the historical global market size for pain management devices?
• What are the market forecasts and estimates for 2024–2031 in the pain management devices sector?
• What are the primary drivers, restraints, opportunities, challenges, and trends influencing the pain management devices market?
• Who are the key players operating in the pain management devices market?
• What does the competitive landscape look like, and which companies are leading in the pain management devices market?
• What recent developments have occurred in the pain management devices market?
• What growth strategies have major players adopted in the pain management devices market?
• What are the geographical trends, and which regions/countries are experiencing rapid growth?
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research